tetano
Editor, Senior Moderator
Prev Med. 2013 Feb 8. pii: S0091-7435(13)00032-7. doi: 10.1016/j.ypmed.2013.01.019. [Epub ahead of print]
Disparities in Pneumococcal and Influenza Immunization among Older Adults in Israel: A Cross-Sectional Analysis of Socio-demographic Barriers to Vaccination.
Schwartz AW, Clarfield AM, Doucette J, Valinsky L, Karpati T, Landrigan PJ, Sternberg SA.
Source
Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY, USA 10029. Electronic address: awschwartz@partners.org.
Abstract
OBJECTIVE:
Vaccinations against influenza and pneumonia reduce morbidity and mortality among older adults. We examined vaccination rates among Israel's diverse geriatric population to determine socio-demographic barriers to vaccination.
METHODS:
This study is a quantitative data analysis with a cross-sectional design, comprising 136,944 patients aged 65 and older enrolled during 2008-2009 in Maccabi Healthcare Services, one of Israel's four Sick Funds (Preferred Provider Organizations). We conducted multivariable logistic regression analyses to determine the association between vaccination status and socio-demographic characteristics, including age, gender, rural residency, socio-economic status, region of origin, immigrant status, and Holocaust survivorship. We controlled for potential confounders, including comorbidities, primary care visits and hospitalizations, as well as the physician's gender and region of origin.
RESULTS:
Overall, vaccination rates were 72% for pneumonia and 59% for influenza. The strongest socio-demographic barriers to vaccination included younger age, female gender, rural residency, low socio-economic status, recent immigration, and being from or having a physician from the Former Soviet Union.
CONCLUSION:
Efforts to further explore barriers to influenza and pneumococcal vaccination and interventions to reduce disparities in vaccination rates should focus on the sub-groups identified in this paper, with careful thought being given as to how to overcome these barriers.
Copyright ? 2012. Published by Elsevier Inc.
PMID:
23402962
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23402962
Disparities in Pneumococcal and Influenza Immunization among Older Adults in Israel: A Cross-Sectional Analysis of Socio-demographic Barriers to Vaccination.
Schwartz AW, Clarfield AM, Doucette J, Valinsky L, Karpati T, Landrigan PJ, Sternberg SA.
Source
Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY, USA 10029. Electronic address: awschwartz@partners.org.
Abstract
OBJECTIVE:
Vaccinations against influenza and pneumonia reduce morbidity and mortality among older adults. We examined vaccination rates among Israel's diverse geriatric population to determine socio-demographic barriers to vaccination.
METHODS:
This study is a quantitative data analysis with a cross-sectional design, comprising 136,944 patients aged 65 and older enrolled during 2008-2009 in Maccabi Healthcare Services, one of Israel's four Sick Funds (Preferred Provider Organizations). We conducted multivariable logistic regression analyses to determine the association between vaccination status and socio-demographic characteristics, including age, gender, rural residency, socio-economic status, region of origin, immigrant status, and Holocaust survivorship. We controlled for potential confounders, including comorbidities, primary care visits and hospitalizations, as well as the physician's gender and region of origin.
RESULTS:
Overall, vaccination rates were 72% for pneumonia and 59% for influenza. The strongest socio-demographic barriers to vaccination included younger age, female gender, rural residency, low socio-economic status, recent immigration, and being from or having a physician from the Former Soviet Union.
CONCLUSION:
Efforts to further explore barriers to influenza and pneumococcal vaccination and interventions to reduce disparities in vaccination rates should focus on the sub-groups identified in this paper, with careful thought being given as to how to overcome these barriers.
Copyright ? 2012. Published by Elsevier Inc.
PMID:
23402962
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23402962